J Pediatr Genet 2012; 01(02): 131-134
DOI: 10.3233/PGE-2012-021
Georg Thieme Verlag KG Stuttgart – New York

The phenotype masks the genotype: A possible new expression of diabetes

Adriana Mimbacas
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Graciela Vitarella
b   Diabetology Unit, Health Center of “Sindicato Médico del Uruguay” (SMU), “Institución de Asistencia Médica de Profesionales Privados (IAMPP)”, Montevideo, Uruguay
,
Jorge Souto
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Ana Laura Reyes
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Joaquina Farias
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Mariana Fernández
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Matias Fabregat
a   Human Genetic Group, Genetic Department, Clemente Estable Biologic Research Institute (IIBCE), Montevideo, Uruguay
,
Gerardo Javiel
b   Diabetology Unit, Health Center of “Sindicato Médico del Uruguay” (SMU), “Institución de Asistencia Médica de Profesionales Privados (IAMPP)”, Montevideo, Uruguay
› Author Affiliations

Subject Editor:
Further Information

Publication History

14 September 2010

19 March 2011

Publication Date:
27 July 2015 (online)

Abstract

The concept of a new form of diabetes, with signs of both types 1 and 2, has not been often considered, until recently. It is of immense interest to explore the role of the admixture that characterizes the Uruguayan population (higher and different from other Latin America countries) for the presence of such expression of that particular disease. We describe here a child who possibly presents with this expression. He had typical signs of both diabetic conditions: type 1 (young age, positive immunologic and genetic markers, ketoacidosis) and type 2 (obesity [body mass index = 36 kg/m2] and acanthosis nigricans). In spite of complying with the established guidelines, therapeutic and nutritional control, quality of life and good metabolic control, the patient's obesity had been continually increasing. Looking for a genetic explanation, we studied three single nucleotide polymorphisms involved in three different metabolic pathways (peroxisome proliferator-activated receptor gamma 2, insulin receptor substrate-1 and uncoupling protein-2) associated with insulin resistance. Our patient showed three mutations, GG, GA, GG, associated with insulin resistance that explains obesity associated with limited response to the commonly used drugs. According to the clinical presentation and the genetic and immunological background, we considered that this patient presents with a new form of diabetes. We have termed this particular disease “hybrid diabetes” because of the involvement of genes associated with both the classical type of diabetes. However, at least in an admixed population such as in Uruguay, clinical classification would not strictly dictate the choice of treatment.